Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Hydromea | 2026 | Grant | Undisclosed | Renens |
| CellPly | 2026 | Venture - Series Unknown | $3.6M | Bologna |
| BiBBInstruments | 2026 | Post-IPO Equity | Undisclosed | Lund |
| Cyclomics | 2026 | Venture - Series Unknown | $3.0M | Utrecht |
| Qualinx | 2026 | Venture - Series Unknown | $23.4M | Delft |
| reTyre | 2026 | Venture - Series Unknown | $8.2M | Ski |
| ChemiCare | 2025 | Seed | $2.9M | Novara |
| Sofi Filtration | 2025 | Grant | $1.0M | Espoo |
| Blubrake | 2025 | Series Unknown | $2.9M | Milan |
| Healthplus.ai | 2025 | Series Unknown | $2.7M | Amsterdam |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Hydromea | Grant | Undisclosed | Renens, Switzerland |
| 2 | CellPly | Venture - Series Unknown | $3.6M | Bologna, Italy |
| 3 | BiBBInstruments | Post-IPO Equity | Undisclosed | Lund, Sweden |
| 4 | Cyclomics | Venture - Series Unknown | $3.0M | Utrecht, The Netherlands |
| 5 | Qualinx | Venture - Series Unknown | $23.4M | Delft, The Netherlands |
| 6 | reTyre | Venture - Series Unknown | $8.2M | Ski, Norway |
| 7 | ChemiCare | Seed | $2.9M | Novara, Italy |
| 8 | Sofi Filtration | Grant | $1.0M | Espoo, Finland |
| 9 | Blubrake | Series Unknown | $2.9M | Milan, Italy |
| 10 | Healthplus.ai | Series Unknown | $2.7M | Amsterdam, The Netherlands |
Automating submerged asset inspections with a remote underwater drone platform
Developing analytical systems to characterize next-generation cancer immunotherapy
BiBBInstruments has develops an instrument that allows quick and easy sampling of suspected cancer tumors by drilling into the tissue.
Cyclomics is a Dutch startup with ambition is to transform cancer care by enabling faster and more reliable diagnoses.
Qualinx is a pioneer in Digital-RF technology developing an ultra-low power single chip solution for GNSS and IoT radios
Award-winning, sustainable tyre manufacturer, and the first company in the world capable of mass-producing reusable, pneumatic tyres.
ChemiCare is committed to the discovery and development of orphan drugs for patients affected by calcium-related genetic diseases.
Sofi Filtration is a Finnish provider of innovative industrial water filtration technology.
Blubrake aims to make future mobility greener, smarter and safer thanks to its cutting-edge technologies for light electric vehicles
Healthplus.ai enables proactive surgery care
Else Nutrition offers plant-based nutrition products for the infant, toddler, children, and adult markets.
Modvion designs, produces, and installs wind turbine towers constructed from engineered wood.
CWS is a family story which was incorporated in 2016 to revive commercial sailing.
Pila Pharma is a TRPV1-platform focused company developing oral treatments for type-2 diabetes, obesity, and pain.
FuVeX is dedicated to the design, manufacture, and commercialization of drones.
Feelit provides printed nonomaterial-based sensing solutions that turns an object to a smart object that provides live performance insights.
Omniflow provides sustainable smart city solutions.
ONEiO is a cloud-native Integration Service Provider
Blixtis a company that offers semiconductor-based circuit breakers and household fuses.
ChemoTech is an innovator in gentle cancer treatment and effective pain management.
Scopio Labs provides digital cell morphology imaging and AI solutions for hematology microscopy and diagnostics.
Arycs Technologies is revolutionizing optical communications.
Kiin delivers immersive learning experiences to help organisations cultivate empathy, inclusive leadership and soft skills.
Colugo is a firm which develops and designs unique unmanned VTOL vehicles.
Ecohelix is a Swedish greentech company leading the way in sustainable wood-based biopolymer technology
EISMEA has invested in 410 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
EISMEA's top investment sectors include Health Care, Renewable Energy, Biotechnology, Semiconductor, Software. The firm invests across 57 different industry categories.
Among tracked funding rounds, Modvion received $45.5M in a Grant round. EISMEA's total known invested capital is $1.0B.
EISMEA's average investment size is $4.1M across its portfolio of 410 companies.
Recent EISMEA portfolio additions include Hydromea, CellPly, BiBBInstruments, Cyclomics, Qualinx. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors